Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
clinical trials
life sciences
4
×
national blog main
deals
fda
national top stories
autoimmune disorders
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alder biopharmaceutical
alexion pharmaceuticals
allergan
allosteric
american academy of neurology
What
potential
4
×
drug
disease
medicines
meeting
new
address
adds
ago
ahead
allosteric
alternative
ambien
american
annual
approval
arguments
asco
attendees
attention
autoimmune
big
biotech
camp’s
cancer
candidate
cash
chicago
city
class
clinic
clinical
combinations
commercialized
community’s
companies
competitors
days
deal
decades
Language
unset
Current search:
potential
×
biotech
×
" life sciences "
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
